Difficulty: Medium
Average Score: 68%
Practice
Treatment with selegilin postpones the need for levodopa for 3-9 months and may retard the progression of ParkinsonÔÇ▓s disease.
Correct answer
A
Rationale
The correct answer is A) TRUE. Selegiline, also known as deprenyl, is a monoamine oxidase inhibitor (MAOI) that is used in the treatment of Parkinson's disease. Selegiline works by increasing levels of dopamine in the brain, which helps alleviate the symptoms of Parkinson's disease. Studies have shown that treatment with selegiline can delay the need for levodopa therapy by 3-9 months.
Option B) FALSE is incorrect because the statement provided in the question is true based on clinical evidence and research studies. Selegiline has been shown to postpone the need for levodopa therapy and may slow down the progression of Parkinson's disease.
Option C) None is incorrect as it does not provide a valid response to the question. This option does not address whether the statement about selegiline and its effects on Parkinson's disease is true or false.
Option D) All of the above is incorrect because it is not applicable to this question; it seems to be a placeholder option that does not relate to the content provided.
Educational Context:
Understanding the pharmacological treatment of Parkinson's disease is crucial for healthcare professionals involved in managing patients with this condition. Knowing the effects of medications like selegiline on disease progression and symptom management is essential for making informed treatment decisions. This question highlights the significance of selegiline in delaying the need for levodopa therapy and potentially slowing down the progression of Parkinson's disease, emphasizing the importance of early intervention and appropriate medication selection in managing this neurodegenerative disorder.
Option B) FALSE is incorrect because the statement provided in the question is true based on clinical evidence and research studies. Selegiline has been shown to postpone the need for levodopa therapy and may slow down the progression of Parkinson's disease.
Option C) None is incorrect as it does not provide a valid response to the question. This option does not address whether the statement about selegiline and its effects on Parkinson's disease is true or false.
Option D) All of the above is incorrect because it is not applicable to this question; it seems to be a placeholder option that does not relate to the content provided.
Educational Context:
Understanding the pharmacological treatment of Parkinson's disease is crucial for healthcare professionals involved in managing patients with this condition. Knowing the effects of medications like selegiline on disease progression and symptom management is essential for making informed treatment decisions. This question highlights the significance of selegiline in delaying the need for levodopa therapy and potentially slowing down the progression of Parkinson's disease, emphasizing the importance of early intervention and appropriate medication selection in managing this neurodegenerative disorder.